Invention Grant
- Patent Title: Bridged heterocyclic compounds and methods of use
-
Application No.: US12410425Application Date: 2009-03-24
-
Publication No.: US08546381B2Publication Date: 2013-10-01
- Inventor: David T. Hung , Andrew Asher Protter , Sarvajit Chakravarty , Rajendra Parasmal Jain
- Applicant: David T. Hung , Andrew Asher Protter , Sarvajit Chakravarty , Rajendra Parasmal Jain
- Applicant Address: US CA San Francisco
- Assignee: Medivation Technologies, Inc.
- Current Assignee: Medivation Technologies, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Morrison & Foerster LLP
- Main IPC: A61K31/54
- IPC: A61K31/54

Abstract:
This disclosure relates to new compounds that may be used to modulate a histamine receptor in an individual. Novel compounds are described, including new bridged heterocyclic [4,3-b]indole compounds. Pharmaceutical compositions are also provided. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
Public/Granted literature
- US20100099667A1 BRIDGED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Public/Granted day:2010-04-22
Information query